Note: Ingredients listed on restricted chemical lists
EC/CAS
233-140-8/10043-52-4
Name of the chemical
calcium chloride
Concentration
>=10-<15
EC/CAS
55965-84-9
Name of the chemical
Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Concentration
>=0,0002-< >=0,6% 0,06-<0,6% 0,06-<0,6% >=0,0015% >=0,6%
General Information
Version
1.1
Revision date
2024-07-24
Product name
imPress ID-235 Surface Sizing Agent
Emergency telephone
+1-302-502-0991, +431 406 43
Icons in SDS
Company Information
company name
Solenis Netherlands B.V
e-mail address of the competent person responsible for the Safety Data Sheet
EHSProductSafetyTeam@solenis.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Warning
Hazard statements
H319 Causes serious eye irritation.
Prevention
P264 Wash skin thoroughly after handling. P280 Wear eye protection/ face protection.
Response
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337 + P313 If eye irritation persists: Get medical advice/ attention.
Additional information
EUH208 Contains mixture of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no.247- 500-7] and 2-methyl-2H-isothiazol-3-one [EC no. 220-239-6] (3:1);. May produce an allergic reaction.
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Eye irritation, Category 2 H319: Causes serious eye irritation.
